Cannabidiol (CBD) Therapy for Anxiety and Anxiety like Behavior

Cannabidiol (CBD) Therapy for Anxiety and Anxiety like Behavior

Medicinal marijuana, also known as cannabinoid medication or medicinal cannabis, is a growing treatment option for a variety of ailments. Anxiety and anxiety-like behavior will be the subject of this post.

Is reliable information about the benefits of cannabinoids being given to patients?

Many individuals, however, express doubt or ambiguity about the advice to use cannabinoid medication or medicinal cannabis. This is a phenomenon that can be seen in both primary and medical marijuana procedures. Some of the issues with recognizing cannabis in medical treatment are revealed in a 2020 report published in the Journal of primary care and environmental health (1). The emphasis of this study was on primary care physicians and patients in Vermont, as well as their perceptions of the treatment.

“The aim of this study was to determine how cannabinoids, such as tetrahydrocannabinol (THC) and cannabidiol (CBD), are used and perceived in adult primary care patients in Vermont. 1009 Vermont primary care patients aged 18 and up were given an anonymous written survey.”

“(The study results focused on) patient-reported outcomes, such as the utilization of CBD and THC drugs, perceived usefulness for some medical conditions, CBD and THC awareness, perceived provider knowledge, and concerns about cannabis legalization.”

Just 18% of patients said their healthcare provider was a reliable source of cannabis-related knowledge.

Cannabinoids were used by 45 percent of adult primary care patients in the previous year. Just 18 percent of patients said their provider was a reliable source of cannabis-related knowledge.

Anxiety and depression, arthritis, pain, sleep, and nausea are all things that cannabis can help with.

The majority of patients who used cannabis in the previous year said it helped them with anxiety and depression, arthritis, pain, sleep, and nausea.

To better help patient care, primary care providers must be informed about cannabinoids.

Final Thoughts: “In order to better facilitate patient care, primary care providers must be informed about cannabinoids. Furthermore, with a large number of patients claiming that cannabinoids are beneficial for medical problems that are often seen in primary care, it is important that research into the possible benefits and harms of cannabis continues.”

Treatment options for patients suffering from anxiety and trauma-related symptoms that are both good and successful

The difficulties of identifying good and appropriate treatment choices for patients suffering from anxiety and trauma-related disorders are discussed in a 2019 research review published in Current psychiatry reports (2). The following is what the researchers had to say:

“Psychological therapies are often ineffective or only temporary, while drugs may be ineffective or cause unintended side effects in a significant number of patients. Psychological treatments can be used in conjunction with drugs to improve patient outcomes, but certain medications can interfere with these therapies. As a result, better treatment services for these conditions are urgently needed.

With the decriminalization of cannabis, the availability of cannabis-derived chemicals (i.e. cannabinoids), and anecdotal evidence for cannabinoids' anxiolytic (anxiety-reducing) potential all in popularity, it's critical to assess the empirical evidence to see whether cannabinoids will live up to their hype as a treatment option for anxiety-related disorders in the future.

In the journal European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology, a research team from Spain published a paper in February 2020:

(3) If you're looking for a

“The active chemical ingredients in cannabis, known as phytocannabinoids, cause a variety of effects on the Central Nervous System. The intoxicating properties of cannabis preparations have been linked to these compounds on several occasions. However, not all phytocannabinoids are psychotropic, and they have a variety of therapeutic properties regardless of whether they are psychotropic or not.

These characteristics are often linked to their ability to modulate the function of an intercellular signaling mechanism known as the endocannabinoid system, which is highly active in the Central Nervous System and has been linked to a variety of neurological disorders.

“...diseases like schizophrenia and associated psychoses, anxiety disorders, mood disorders, addiction, sleep disorders, post-traumatic stress disorder, and anorexia nervosa”

This includes diseases such as schizophrenia and related psychoses, anxiety-related disorders, mood disorders, addiction, sleep disorders, post-traumatic stress disorder, anorexia nervosa and other feeding-related disorders, dementia, epileptic syndromes, as well as autism, fragile X syndrome (a developmental disorder marked by delays in tetralogy of Fallot), and fragile X syndrome (a developmental disorder marked by delays in tetralogy of Fallot).

Examining the evidence to see whether cannabinoids would benefit people who suffer from anxiety

The latest evidence on the safety and efficacy of cannabidiol (CBD) in anxiety and anxiety-related disorders was examined in a December 2019 review (4) published in the Journal of the American Pharmacists Association.

The research team evaluated the function of CBD in the anxiety response of healthy volunteers, generalized anxiety disorder, social anxiety disorder, and the anxiety aspect of posttraumatic stress syndrome after reviewing eight medical studies.

CBD was given orally as a capsule or a sublingual spray in the trials, and it was used as a monotherapy or adjunctive therapy. Doses ranged from 6 mg to 400 mg per dose, with experiments using fixed CBD doses ranging from 6 mg to 400 mg per dose. The research used a variety of anxiety assessment scales to determine effectiveness, with CBD showing enhanced clinical results across the board. CBD was generally well tolerated and associated with few side effects, with fatigue and sedation being the most widely reported side effects.”

CONCLUSION: “CBD has a promising future as an alternative treatment for anxiety disorders. More research with standardized dosing methods and clinical outcome measurements is required, however, to evaluate the best CBD dosing strategy and its place in therapy.” The results in panic disorder, specific phobia, separation anxiety, and obsessive-compulsive disorder were not included in the studies studied, according to the researchers.

The researchers provide a fact-based assessment of CBD's function in anxiety disorders, emphasizing the importance of dose and patient selection in treatment success. We concur.

Is it possible to counteract anxiety-like actions in late adolescence with cannabidiol?

The accumulated empirical evidence suggests that cannabidiol (CBD) reverses anxiety-like behavior, according to a November 2019 report published in the journal Frontiers in psychology (5). This Japanese research looked at adolescents with a social anxiety disorder to see if this theory was true (SAD).

In a four-week double-blind study, 37 18–19-year-old Japanese teenagers with SAD and avoidant personality disorder were given either cannabis oil (17 study participants) containing 300 mg CBD or a placebo (20 study participants) daily.

The Fear of Negative Evaluation Questionnaire and the Liebowitz Social Anxiety Scale were used to assess SAD symptoms at the start and end of the treatment period. CBD reduced anxiety on both scales in a meaningful way. The findings suggest that CBD may be an effective treatment for social anxiety.

Findings: “Overall, the findings of this study show that frequent CBD administration has anxiolytic effects in adolescents with social anxiety disorder.”

Recognizing the treatment

The research team proposed that cannabinoid-related drugs could be used in different ways to treat anxiety disorders in the study cited above, which was published in Current psychiatry studies (6). SSRI (Selective serotonin reuptake inhibitors) or SNRI (Serotonin-norepinephrine reuptake inhibitor) therapy can be used as a supplement to first-line depression and anxiety drugs. Cannabinoid-related drugs may be a better alternative to benzodiazepines, which are more likely to be abused and have a worse side effect profile. More research is required, according to the researchers, to determine the true profit.

A full history and physical examination will be conducted by a licensed health care professional at the Magaziner Center. Not only will you be granted a medical marijuana passport, but you will also be given a thorough and holistic assessment of your medical health. This is only one of the many resources we have available to assist you with your wellbeing. Our medical staff will create a personalized package for you that includes the best delivery method and cannabis strain-specific recommendations. Our method ensures that you're on the right track when it comes to using this herb as true medicine.

Source: Magaziner Center for Wellness